Study finds success in non-chemo lymphoma treatment BOSTON -- Researchers at the National Institutes of Health found a new treatment for lymphoma that is not chemotherapy. The recent study focused ...

Incorporating brentuximab vedotin into the treatment of advanced-stage classic Hodgkin’s lymphoma improves outcomes in adult and pediatric patients. However, brentuximab vedotin increases the ...

In July 2020, Monjuvi in combination with lenalidomide received FDA approval for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise ...